Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer

Prognosis for patients with non-small cell lung cancer (NSCLC) is poor. The potential value of modulating EGFR for treatment is reflected by the recent approval of specific drugs that inhibit its activity. Mutations in EGFR were reported in lung cancer and generated interest, once they enable the id...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hoque, Mohammad Obaidul, Brait, Mariana, Rosenbaum, Eli, Poeta, Maria Luana, Pal, Prodipto, Begum, Shahnaz, Dasgupta, Santanu, Carvalho, Andre L, Ahrendt, Steven A., Westra, William H, Sidransky, David
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3057519/
https://ncbi.nlm.nih.gov/pubmed/21102258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181f77a53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares